Newsletter
| Promoter: | Penny Stock Titans | Paying Party: | Ramos & Ramos LLC |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| AXXE | $21000 | UNKNOWN |
| Max Profit: 7.03 % | Gain at close: 0.00 % | |
| *We think that this promoter is a part of a group of promoters. | ||
 |
Disclaimer | Privacy Policy |
AXXE COULD BE AT GROUND-FLOOR LEVELS!
Good Morning Traders,
2015 could be the year AXXE gets off the runway and soars to new highs!
At under 20 cents this could be a huge ground-floor opportunity right now. A similar company in the industry, MusclePharm (MSLP) traded as high as $14 last year!
This is what has us so excited about AXXE!
The company has had so much news over the year and has been on an aggressive path towards getting recognized. At these levels you can't afford to look away!
We see massive potential for upside right now and triple digit gains could be on the way!
At under 20 cents the stock could be a huge bargain!!
The key is to always know something before the rest of the crowd does when it comes to Wall Street.
While AXXE is still a hidden gem, this is your chance to do your research and have it on your watch list!
About the Company:
Headquartered in Canada, AXXE is a specialty pharmaceutical and nutritional supplements company, that works through its wholly owned subsidiary, AllStar Health Brands Inc.
TapouT is a huge name in the UFC. In just a dozen years, UFC has grown into an enterprise valued at $2 billion with fans across the world.
Millions of customers from around the world visit TapouT.com each month.
Tapout.com was the FIRST website offering AXXE's line of topical pain relief and muscle recovery products to go along with its own core offerings.
Last year AXXE began online sales through Amazon.com, RonnieColemannutrition.com, Go4itNutrition.com, and TapouTMuscle Recovery.com and several other sites.
The US Military (Army Air force Exchange Service- AAFES) is now the company's biggest customer right now.
This year could be the year that AXXE gets their products into BIG BOX RETAIL CHAIN STORES!
Big retail chains selling AXXE's products could quickly gain exposure for the company and help it achieve much bigger revenues. In turn this could also create significant shareholder value!
The company just recently got back from the National ECRM event with strong interest from both big box retail chain stores and large-chain specialty stores. Follow-up has begun and is anticipated to generate orders in the near-term.
Big box retail chains and specialty stores had a strong interest the TapouT line of products with particular interest in the new TapouT Turbo Blend Protein Powder, and soon to-be launched Protein Shakes.
Russ Greenberg, Director of Sales for AXXE, stated, "We are excited to receive such strong interest from retail outlets. The buyer's goal is to increase sales to their retail outlets, bring new exciting brands in to increase their ROI on shelf space and offer healthy options to their consumers as well as develop repeat sales and customers."
AXXE will also be presenting their full TapouT line of products at the nation's largest health and fitness expo, known as the "The Arnold Fitness Expo."
Over 175,000 fitness enthusiasts will be attending the three day non-stop event and competitions, including the Arnold Strongman Classic, and Arnold Arm Wrestling Classic.
The Expo will be held March 5th through 8th in Columbus, Ohio and is known for connecting health and fitness companies with chain store buyers from across the world.
Last year AXXE had so many positive developments and 2015 has been projected to be a major year for the company. Big plans include a shareholder dividend and national exposure on television and major sporting events!
The company has retained Acosta, a leading sales and marketing firm serving the markets top consumer goods retail companies such as Kellog's, Cambell's and The Clorox Company!
We very RARELY see a penny stock up to this much!
Could AXXE be ready to soar over $1.00 and follow in MSLP's footsteps?
With plans for national exposure next year, it may just be a matter of time that AXXE starts selling in many major stores. Could GNC and Wal-Mart be on the way?
Company Website: http://www.axxesspharma.com
Keep your eyes on AXXE for some huge potential upside!
Sincerely,
PennyStockTitans
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY
We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Pennystocktitans.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Pennystocktitans.com or an offer or solicitation to buy or sell any securities.
None of the owners of Pennystocktitans.com, or any of its members, officers, directors, contractors or employees is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Pennystocktitans.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Pennystocktitans.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Pennystocktitans.com has no obligation to update any of the information provided, nor is it responsible for errors and omissions.
From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our releases or on our website may not have approved certain or any statements within the release or website. Pennystocktitans.com encourages viewers to supplement the information obtained from any release or our website with independent research and other professional advice. By accessing, viewing, or using our website or communications originating from our website or any release therein, you agree that Pennystocktitans.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Pennystocktitans.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
Pennystocktitans.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold Pennystocktitans.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. Pennystocktitans.com disclaims all warranties of any kind, express or implied. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org . In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm.
Questions regarding any information contained in this website may be sent to info@pennystocktitans.com To review our complete disclaimer and additional information, please visit www.pennystocktitans.com
COMPANY SPECIFIC DISCLAIMER
Some of the content in this release may contain forward-looking information within the meaning of Section 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the profiled companies and the value of their securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. The company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in our releases. A company's past performance does not guarantee future results. Further specific financial information, filings and disclosures as well as general investor information about the profiled companies, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org.
The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. This release may provide hyperlinks to third party websites or access to third party content. Pennystocktitans.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Pennystocktitans.com control, endorse, or guarantee any content found in such sites.
Pennystocktitans.com has been compensated $21,000.00 from Ramos and Ramos for the 1 day profile of Axxess Pharma (OTCBB:AXXE) which services include the issuance of this release and other opinions that we release concerning of Axxess Pharma (OTCBB:AXXE) Pennystocktitans.com has not investigated the background of Ramos and Ramos, the hiring party, or Axxess Pharma (OTCBB:AXXE). Anyone viewing this newsletter should assume Ramos and Ramos or affiliates of Ramos and Ramos own shares of Axxess Pharma (OTCBB:AXXE). of which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. Pennystocktitans.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements on Axxess Pharma (OTCBB:AXXE).
|
This message was sent to xxxxxx@gmail.com from: Penny Stock Titans | info@pennystocktitans.com | Penny Stock Titans | 433 Plaza Real Suite 275 | Boca Raton , FL 33432 |
Email Marketing by |
